We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Data from Eloxx’s proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in late-breaking presentation at American Society of Nephrology (ASN) Kidney Week New...
First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential treatment of rare dermatological and other diseases associated with nonsense mutations...
Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutationsZKN-013 is a phase I...
VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and Almirall S.A. (BME: ALM), a global...
VANCOUVER, British Columbia, March 21, 2022 (GLOBE NEWSWIRE) -- Alliance Mining Corp. (TSXV:ALM) announced results from its Fall, 2021, prospecting and sampling program on its Red Rice Lake gold...
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and Healthcare products Regulatory Agency and will initially be available for prescription in the UK and...
REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a pioneer in providing minimally invasive treatment for patients with severe lung disease, welcomes...
L'OCRCVM permet la reprise de la négociation - ALM; RHC Canada NewsWire VANCOUVER, le 17 oct. 2018 VANCOUVER, le 17 oct. 2018 /CNW/ - Reprise des négociations pour : Société : ALLIANCE...
IIROC Trading Resumption - ALM; RHC Canada NewsWire VANCOUVER, Oct. 17, 2018 VANCOUVER, Oct. 17, 2018 /CNW/ - Trading resumes in: Company: ALLIANCE MINING CORP. TSX-Venture Symbol:...
Suspension de la négociation par l'OCRCVM - ALM Canada NewsWire VANCOUVER, le 15 oct. 2018 VANCOUVER, le 15 oct. 2018 /CNW/ - L'OCRCVM a suspendu la négociation des titres suivants :...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.085 | 0.085 | 0.085 | 0 | 0 | CS |
4 | -0.115 | -57.5 | 0.2 | 0.2 | 0.085 | 4650 | 0.1397043 | CS |
12 | 0 | 0 | 0.085 | 0.2 | 0.07 | 3153 | 0.14364247 | CS |
26 | -0.015 | -15 | 0.1 | 0.2 | 0.07 | 1956 | 0.12699472 | CS |
52 | 0.005 | 6.25 | 0.08 | 0.2 | 0.07 | 2221 | 0.11023634 | CS |
156 | -0.195 | -69.6428571429 | 0.28 | 0.39 | 0.07 | 4245 | 0.15875178 | CS |
260 | 0.08 | 1600 | 0.005 | 1.15 | 0.005 | 21927 | 0.06646387 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions